×
S&P 500   3,845.08
DOW   31,037.68
QQQ   288.80
S&P 500   3,845.08
DOW   31,037.68
QQQ   288.80
S&P 500   3,845.08
DOW   31,037.68
QQQ   288.80
S&P 500   3,845.08
DOW   31,037.68
QQQ   288.80
NASDAQ:PRTA

Prothena Earnings Date, Estimates & Call Transcripts (2022)

$29.60
-0.09 (-0.30%)
(As of 07/6/2022 12:00 AM ET)
Add
Compare
Today's Range
$29.33
$31.42
50-Day Range
$22.73
$31.26
52-Week Range
$21.06
$79.75
Volume
304,317 shs
Average Volume
437,632 shs
Market Capitalization
$1.39 billion
P/E Ratio
24.26
Dividend Yield
N/A
Price Target
$71.00

Earnings Summary

Upcoming
Earnings Date
Aug. 4Estimated
Actual EPS
(May. 5)
-$0.78 Beat By $0.07
Consensus EPS
(May. 5)
-$0.85
Last Year's Q2 EPS
(5/10/2021)
-$0.91
Skip Charts & View Estimated and Actual Earnings Data

PRTA Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

PRTA Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Prothena Earnings Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany Guidance
Q1 20221($0.83)($0.83)($0.83) 
Q2 20222($1.02)($0.84)($0.93) 
Q3 20222($1.11)($0.87)($0.99) 
Q4 20221($0.89)($0.89)($0.89) 
FY 20226($3.85)($3.43) ($3.64)

PRTA Earnings Date and Information

Prothena last issued its quarterly earnings data on May 5th, 2022. The biotechnology company reported ($0.78) EPS for the quarter, topping the consensus estimate of ($0.85) by $0.07. The business had revenue of $1.15 million for the quarter, compared to analyst estimates of $0.23 million. Prothena has generated $1.22 earnings per share over the last year ($1.22 diluted earnings per share) and currently has a price-to-earnings ratio of 24.3. Earnings for Prothena are expected to decrease in the coming year, from ($2.53) to ($2.88) per share. Prothena has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, August 4th, 2022 based off prior year's report dates.

Prothena Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
8/4/2022
(Estimated)
        
5/5/2022Q1 2022($0.85)($0.78)+$0.07($0.78)$0.23 million$1.15 million
2/17/2022Q4 2021($0.74)($0.71)+$0.03($0.71)$0.28 million$1.17 million    
11/4/20219/30/2021$2.25$2.13($0.12)$2.13$140.08 million$139.17 million
8/5/20216/30/2021$0.56$0.58+$0.02$0.58$60.14 million$60.07 million
5/10/2021Q1($0.80)($0.91)($0.11)($0.91)$0.17 million$0.16 million    
2/10/202112/31/2020($0.77)($0.77)($0.77)$0.20 million$0.36 million  
11/4/20209/30/2020($0.68)($0.77)($0.09)($0.77)$0.53 million$0.16 million  
8/6/20206/30/2020($0.64)($0.66)($0.02)($0.66)$0.18 million$0.20 million
5/6/20203/31/2020($0.57)($0.59)($0.02)($0.59)$0.23 million$0.14 million
2/12/2020Q4($0.65)($0.54)+$0.11($0.54)$0.20 million$0.26 million  
11/5/2019Q3($0.54)($0.49)+$0.05($0.49)$0.15 million$0.21 million  
8/6/2019Q2($0.56)($0.40)+$0.16($0.40)$0.22 million$0.17 million
5/7/20193/31/2019($0.60)($0.52)+$0.08($0.52)$0.20 million$0.19 million  
2/14/201912/31/2018($0.55)($0.59)($0.04)($0.62)$0.28 million$0.19 million  
11/6/20189/30/2018($1.05)($0.62)+$0.43($0.78)$0.26 million$0.26 million  
8/7/20186/30/2018($1.13)($0.98)+$0.15($0.46)$0.22 million$0.28 million
5/8/20183/31/2018($1.23)($1.26)($0.03)($1.26)$31.45 million$0.23 million
2/14/2018After Market($1.48)($1.24)+$0.24($1.24)$0.27 million$0.23 million  
11/7/2017Q3($1.41)($1.37)+$0.04($1.37)$0.28 million$0.19 million
8/8/20176/30/2017($0.89)($0.46)+$0.43($0.46)$16.08 million$26.81 million
5/9/20173/31/2017($1.32)($0.99)+$0.33($0.99)$0.26 million$0.26 million
2/14/2017Q4 2016($1.24)($1.41)($0.17)($1.41)$5.35 million$0.20 million  
11/1/2016Q3 2016($1.23)($1.26)($0.03)($1.26)$0.49 million$0.29 million
8/2/2016Q2 2016($0.89)($1.18)($0.29)($1.18)$0.39 million$0.33 million
5/3/2016Q1 2016($0.70)($0.81)($0.11)($0.81)$0.27 million$0.27 million
2/18/2016Q4 2015($0.79)($0.76)+$0.03($0.76)$0.39 million$0.31 million  
11/2/2015Q3 2015($0.66)($0.73)($0.07)($0.73)$0.28 million$0.43 million
8/4/2015Q2 2015($0.57)($0.59)($0.02)($0.59)$0.60 million$0.28 million
5/5/2015Q1 2015($0.59)($0.55)+$0.04($0.55)$1.95 million$0.59 million
3/5/2015Q4 2014($0.65)($0.48)+$0.17($0.48)$1.20 million$2.00 million
11/3/2014Q3 2014($0.61)($0.48)+$0.13($0.48)$1.13 million$1.50 million
8/4/2014Q2 2014($0.01)$0.06+$0.07$0.06$15.17 million$15.12 million  
5/5/2014Q1 2014$0.81$0.78($0.03)$0.78$30.17 million$32.23 million
3/6/2014Q4 2013($0.45)($0.52)($0.07)($0.52)$0.13 million$0.17 million
11/12/2013Q3 2013($0.62)($0.55)+$0.07($0.55)$0.14 million$0.17 million
8/12/2013Q2 2013($0.53)($0.64)($0.11)($0.64)$0.14 million$0.17 million
5/14/2013Q1 2013($0.51)($0.51)($0.51)$0.17 million
3/28/2013Q412($0.82)($0.82)$0.13 million$0.58 million












Prothena Earnings - Frequently Asked Questions

When is Prothena's earnings date?

Prothena has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, August 4th, 2022 based off last year's report dates. Learn more on PRTA's earnings history.

Did Prothena beat their earnings estimates last quarter?

In the previous quarter, Prothena (NASDAQ:PRTA) reported ($0.78) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.85) by $0.07. Learn more on analysts' earnings estimate vs. PRTA's actual earnings.

How much revenue does Prothena generate each year?

Prothena (NASDAQ:PRTA) has a recorded annual revenue of $200.58 million.

How much profit does Prothena generate each year?

Prothena (NASDAQ:PRTA) has a recorded net income of $66.97 million. PRTA has generated $1.22 earnings per share over the last four quarters.

What is Prothena's price-to-earnings ratio?

Prothena (NASDAQ:PRTA) has a trailing price-to-earnings ratio of 24.26.

What is Prothena's EPS forecast for next year?

Prothena's earnings are expected to decrease from ($2.53) per share to ($2.88) per share in the next year.

More Earnings Resources from MarketBeat

Upcoming Earnings:
This page (NASDAQ:PRTA) was last updated on 7/7/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer.